SCP Vitalife Partners II LP, 10% Owner at Recro Pharma, Inc. (REPH), sold 24,130 shares at $7.96 ($190K) on 2017-02-14, disclosed to the SEC on 2017-03-20.
Open-market sale of $190k REPH by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.96 | 2,293 | $18K | 9.6% |
| 2 | $7.96 | 2,293 | $18K | 9.6% |
| 3 | $7.88 | 6,479 | $51K | 26.8% |
| 4 | $7.88 | 6,479 | $51K | 26.8% |
| 5 | $7.86 | 3,293 | $26K | 13.6% |
| 6 | $7.86 | 3,293 |
| $26K |
| 13.6% |
| Total | $7.89 avg | 24,130 | $190K | 100% |
| Filing → |
| REPH | SELL | 2018-01-08 | $42K | — | Filing → |
| REPH | SELL | 2018-01-04 | $689K | — | Filing → |
| REPH | SELL | 2018-01-02 | $338K | — | Filing → |